A critical advance in cancer study is occurring with the use of mini-antibodies to reactivate damaged p53. This essential malignant suppressor protein is frequently lost in various types of tumors, causing uncontrolled https://friendlybookmark.com/story21820080/vhh-fragments-restore-tumor-suppressor-p53-the-new-hope-for-cancer-management